Cancer stem cell surface markers on normal stem cells

Area of Science:

• Stem cell biology
• Cancer research
• Molecular oncology

Background:

• The cancer stem cell (CSC) hypothesis posits that eliminating CSCs could eradicate cancer.
• CSC surface markers are key targets for developing molecularly targeted therapies and therapeutic antibodies.
• Many identified CSC markers are also found on human embryonic stem cells (hESCs) or adult stem cells.

Purpose of the Study:

• To review and categorize known CSC surface markers.
• To analyze the expression patterns of CSC markers in hESCs, adult stem cells, and normal tissue cells.
• To discuss the implications of these expression patterns for targeted cancer therapies.

Main Methods:

• Literature review and classification of 40 known CSC surface markers.
• Analysis of marker expression across embryonic stem cells, adult stem cells, and normal tissue cells.
• Categorization based on expression profiles in different cell types.

Main Results:

• Approximately 73% of CSC surface markers are also present on embryonic or adult stem cells and rarely expressed on normal tissues.
• The remaining CSC markers show considerable expression in normal tissue cells, with some validated by multiple research groups.
• Categorization reveals distinct expression patterns relevant to therapeutic targeting.

Conclusions:

• Surface markers from hESCs represent a promising source for discovering novel CSC markers.
• Understanding marker expression in normal tissues is critical for developing specific and safe targeted therapies.
• Categorization aids in evaluating the potential of CSC surface markers for clinical applications.